Phillip E. Korenblat, MD FAAAAI Lectureship: Investing Together in Our Future
Phillip E. Korenblat, MD, FAAAAI, is Professor of Clinical Medicine at Washington University School of Medicine and a member of its mentorship board for internal medicine residents. Korenblat began his allergy/immunology (A/I) career in private practice in 1966 at Associated Specialists in Medicine, P.C. in St. Louis. He transitioned to Barnes Jewish West County Hospital as the first Chief Medical Staff Physician in 1990 and established The Clinical Research Center, which was the first dedicated center for asthma in the St. Louis community. He currently is Co-Director/Principal Investigator at The Clinical Research Center.
Over the course of his distinguished career, Korenblat has been a caring physician, as well as a physician educator and mentor to many young physicians. His passion for mentoring motivated his decision to accept a named lectureship.
“Throughout my career, I have tried to be a resource to young physicians. It’s very important to me to facilitate their entrance into the specialty and to encourage them to excel academically,” said Korenblat.
The lectureship, Phillip E. Korenblat, MD, FAAAAI, Lectureship: Investing Together in Our Future, has been fully funded through private donations. Any additional funds donated to the lectureship go to the AAAAI Foundation’s Grow Allergy & Immunology Now (GAIN) Campaign, a cause Korenblat has supported for years.
The GAIN Campaign directly benefits young specialists by granting several Faculty Development Awards every year and allows research and interest in the specialty to grow.
“I look at the future of the practice of allergy and I have some concerns,” said Korenblat. “Allergy programs are being folded into other subspecialties when they should instead be strengthened. The AAAAI and Foundation are vital in providing grants which allow our young investigators, who will become the future leaders in our specialty, to continue to advance A/I.”
Korenblat has made his own lasting contributions to the specialty, not only through his clinical work but academically as well. He has completed over 300 clinical research studies and has published extensively, including co-editing two editions of the textbook, Allergy Theory and Practice, with H. James Wedner, MD, FAAAI.
Within the 1984 edition, he published the first guidelines for the management of asthma, which introduced the concept of using the “mild, moderate and severe classification.” In 1968, Korenblat, with co-investigators, published the first evidence of tolerance in humans to oral ingested dietary antigen bovine serum albumin, was the first to present data demonstrating the requirement of multiple doses of epinephrine for the treatment of anaphylaxis, and published the first data establishing the mechanism responsible for osteoporosis that occurs from systemic mastocytosis with colleagues.
“I try to assist the Foundation and the research its young investigators produce in any way that I can. The lectureship was a natural extension and it gives me satisfaction in knowing that the Foundation will continue to be supported,” said Korenblat.
Dr. Korenblat's Lectureship was established in 2017. The first Lecture in his name will be delivered at the 2018 AAAAI/WAO Joint Congress in Orlando.
The AAAAI Foundation and Phillip E. Korenblat, MD FAAAAI Lectureship is privately funded. If you wish to contribute in his honor, Dr. Korenblat asks that you make donations to the AAAAI Foundation's GAIN Campaign, to fund research that leads to the prevention and cure of asthma and allergic and immunologic disease. Dr. Korenblat will be notified of your gift in honor, and your name will be listed as a donor in the Annual Report of the AAAAI Foundation. Your donation makes a difference. We appreciate your support and your commitment to our specialty.
To make a contribution by phone, contact the AAAAI Foundation Office at (414) 272-6071.